Tandem Diabetes Care (TNDM) Other financing activities (2015 - 2024)
Tandem Diabetes Care's (TNDM) quarterly Other financing activities came in at $183000.0 in Q1 2024, up 357.75% on a QoQ basis from -$71000.0 in Q3 2023.
Tandem Diabetes Care (TNDM) Other financing activities (2015 - 2024) Analysis & Trends
Tandem Diabetes Care (TNDM) has 9 years of Other financing activities data on file, last reported at $183000.0 in Q1 2024.
- Quarterly Other financing activities changed N/A year-over-year to $183000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $183000.0 (up 357.75% YoY) and the FY2024 annual result came in at $183000.0, up 357.75% from the prior year.
- Other financing activities climbed to $183000.0 in Q1 2024, from -$71000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $2.0 million in Q2 2020 to a low of -$2.9 million in Q4 2020.
- A 5-year average of -$40000.0 and a median of $41500.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2021 — Other financing activities soared 6157.14% — and 2022, when it plunged 96.35%.
- Tracing TNDM's Other financing activities over 5 years: stood at -$2.9 million in 2020, then soared by 79.8% to -$593000.0 in 2021, then dropped by 13.83% to -$675000.0 in 2022, then soared by 89.48% to -$71000.0 in 2023, then surged by 357.75% to $183000.0 in 2024.
- The last three Other financing activities figures came in at $183000.0 (Q1 2024), -$71000.0 (Q3 2023), and -$675000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 183,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Sep 30, 2023 | -71,000.00 |
| Sep 30, 2023 | -71,000.00 |
| Dec 31, 2022 | -675,000.00 |
| Dec 31, 2022 | -675,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | -593,000.00 |
| Dec 31, 2021 | -593,000.00 |
| Sep 30, 2021 | 155,000.00 |
| Sep 30, 2021 | 155,000.00 |
| Mar 31, 2021 | 438,000.00 |
| Mar 31, 2021 | 438,000.00 |
| Dec 31, 2020 | -2.94 Mn |
| Dec 31, 2020 | -2.94 Mn |
| Sep 30, 2020 | 899,000.00 |
| Sep 30, 2020 | 899,000.00 |